MiR-29b-3p and miR-181b-5p, shown to repress TCL1A, inversely correlated in their expression with TCL1A levels across CLL subsets defined by features of clinical aggressiveness [102]. Here, TCL1A is linked to B-cell chronic lymphocytic leukemia.